These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 981091)

  • 1. Exertional hypotension due to postganglionic sympathetic blocking drugs.
    Talbot S; Gill GW
    Postgrad Med J; 1976 Aug; 52(610):487-91. PubMed ID: 981091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure.
    Talbot S; Smith AJ
    Br Heart J; 1975 Oct; 37(10):1059-63. PubMed ID: 127594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of blood-pressure during chronic administration of postganglionic sympathetic blocking drugs for hypertension.
    Goldberg AD; Raftery EB
    Lancet; 1976 Nov; 2(7994):1052-4. PubMed ID: 62901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.
    Talbot S; O'Malley BC; Bing RH
    Br Med J; 1975 May; 2(5965):278. PubMed ID: 1131592
    [No Abstract]   [Full Text] [Related]  

  • 5. Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
    Talbot S
    Cardiology; 1976; 61(4):254-66. PubMed ID: 13931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroergotamine: an effective treatment for postural hypotension due to antihypertensive drugs (ganglion-blocking agents excepted).
    Conté JJ; Fournié GJ; Maurette MH
    Cardiology; 1976; 61 suppl 1():342-9. PubMed ID: 135643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
    Chalmers AG; Hunter J; Lees CD; Millar JA; Brown JJ; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):183S-187S. PubMed ID: 526399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanethidine, exercise, and hypotension.
    Barker LR
    Lancet; 1976 Dec; 2(7998):1297. PubMed ID: 63762
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of hypertension with propranolol.
    Prichard BN; Gillam PM
    Br Med J; 1969 Jan; 1(5635):7-16. PubMed ID: 5761914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TO-DAY'S DRUGS. BETHANIDINE SULPHATE.
    BEWLEY TH
    Br Med J; 1964 Oct; 2(5413):865. PubMed ID: 14185642
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of exercise hypotension after sympathetic blockade.
    Khatri IM; Cohn JN
    Am J Cardiol; 1970 Mar; 25(3):329-38. PubMed ID: 5443912
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological effects of [(octahydro-2-azocinyl)methyl] guanidine(guanazodine): its action mechanism and hypotensive effect].
    Shimizu T; Hamakawa H; Tozuka T; Ono H
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):837-50. PubMed ID: 1035187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE EFFECTS OF BETHANIDINE ON THE PERIPHERAL CIRCULATION IN MAN.
    FEWINGS JD; HODGE RL; SCROOP GC; WHELAN RF
    Br J Pharmacol Chemother; 1964 Aug; 23(1):115-22. PubMed ID: 14208188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiclinic controlled trial of bethanidine and guanethidine in severe hypertension.
    Ramirez EA; Elson L; Gear AS; Oster JR; Talmers FN; Thomas JR
    Circulation; 1977 Mar; 55(3):519-25. PubMed ID: 319922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs in hypertension.
    Myers MG
    Can Med Assoc J; 1977 Jan; 116(2):173-6. PubMed ID: 343894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of alpha-methyldopa and guanethidine on hemodynamic shifts in the orthostatic position in patients with arterial hypertension].
    Glezer GA; Moskalenko NP
    Kardiologiia; 1972 Dec; 12(12):55-60. PubMed ID: 4661921
    [No Abstract]   [Full Text] [Related]  

  • 17. Side effects of hypotensive agents evaluated by a self-administered questionnaire.
    Bulpitt CJ; Dollery CT
    Br Med J; 1973 Sep; 3(5878):485-90. PubMed ID: 4726158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New sympathoplegic antihypersensive agent: debrisoquin sulfate].
    Biron P
    Union Med Can; 1973 May; 102(5):1134-5. PubMed ID: 4712043
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of debrisoquine and guanethidine in treatment of hypertension.
    Adi FC; Eze CJ; Anwunah A
    Br Med J; 1975 Mar; 1(5956):482-5. PubMed ID: 1125586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
    Bartsch W; Sponer G; Strein K; Böhm E; Hooper RG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S49-51. PubMed ID: 2454367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.